Design, Synthesis, and Reactivity of Bimetallic Complexes of Dimethylplatinum(II) Containing Ditopic Ligands

This thesis describes a study of monometallic and bimetallic dimethylplatinum(II) complexes containing ditopic nitrogen donor ligands. This work details the design and synthesis of side-to-side and cofacial arranged ligands and their respective coordination chemistry. The study of the synthesis, characterization and reaction mechanisms of the various dimethylplatinum(II) complexes is outlined in detail with special emphasis focused on the reactivity of the complexes towards oxidative addition. The ditopic ligand 6-dppd, 1,4-di(2-pyridyl)-5,6,7,8,9,10-hexahydrocycloocta[d]pyridazine, was observed to coordinate only a single equivalent of a platinum(II) center. The inability to coordinate a second equivalent, even through an assisted bridging atom, is presumed to be due to a steric clash between the free pyridyl group and the cyclooctyl backbone. In attempts to make heterobimetallic complexes of 6-dppd, the complex [PtMe2(6-dppd)] was observed to react preferentially with mercuric halides by oxidative addition rather than coordination of the mercuric salt in the second coordination site giving complexes [PtXMe2(HgX)(6-dppd)] where X = Br, Cl, OAc. This indicates that the platinum center is actually a better nucleophile than the free pyridyl nitrogen atom. The oxidative addition of solvent dichloromethane was also observed showing the enhanced reactivity of [PtMe2(6-dppd)]. Finally, [PtMe2(6-dppd)] was treated with DCl at low temperature to give the deuteridoplatinum(IV) complex. The deuteridoplatinum(IV) complex reductively eliminates methane in solution and extensive H/D exchange occurs into the CH4 product at low temperature indicating very easy reversibility of the exchange between hydridomethylplatinum(IV) and methaneplatinum(II) complexes. The abstraction of a chloride ligand from [PtClMe(6-dppd)] led to the formation of a complex dimer structure endo,endo-[Pt2Me2(µ2-κ3-6-dppd)2][OTf]2. This process allowed for the formation of a bimetallic platinum(II) complex which retained the initial stereochemistry. The protonolysis of [PtMe2(6-dppd)] with one equivalent of HOTf led to the generation of methane gas and the concomitant formation of both endo,endo-[Pt2Me2(µ2-κ3-6-dppd)2][OTf]2 and exo,exo-[Pt2Me2(µ2-κ3-6-dppd)2][OTf]2. The structures of the exo isomeric clamshell dimers appeared much less sterically hindered in the solid state and were observed experimentally and computationally to be the thermodynamically preferred isomers. The mechanism, selectivity and reversibility of this isomerism process was explored in detail. The reactions of [PtMe2(6-dppd)] with alkyl bromides RCH2Br, which possess hydrogen bonding functionality, result in the formation of stable organoplatinum(IV) complexes capable of forming supramolecular structure via hydrogen bonding. Both intra and inter molecular hydrogen bonding is observed in the formation of supramolecular architectures which self-assemble in the solid state through additional π-stacking and weak secondary interactions. The new anthracene derived ditopic ligands, bpad = N1,N8-bis(pyridin-2-ylmethylene)anthracene-1,8-diamine and adpa = (N,N)-4,4’-(anthracene-1,8-diylbis(ethyne-2,1-diyl))-bis(N-(pyridin-2-ylmethylene)aniline) were prepared, characterized and used to coordinate dimethylplatinum(II) centers giving cofacial bimetallic complexes of dimethylplatinum(II). [Pt2Me4(bpad)] was shown to degrade over time in solution through a proposed metalation event involving the anthracene backbone. The oxidative addition of a variety of substrates was performed using [Pt2Me4(adpa)] giving stable diplatinum(IV) complexes as characterized by 1H NMR spectroscopy. The new xanthene derived ditopic ligands, ppxda = 2,7-di-tert­-butyl-9,9-dimethyl-N4,N5-bis(4-(pyridin-2-ylmethyleneamino)phenyl)-xanthene-4,5-dicarboxamide and pmxda = 2,7-di-tert-butyl-9,9-dimethyl-bis(pyridine-2-ylmethylene)-9H-xanthene-4,5-diamine were prepared, characterized and used to ligate two equivalents of a dimethylplatinum(II) center. Diplatinum complexes of both ligands were shown to easily undergo oxidative addition to give the corresponding diplatinum(IV) complexes which adopt the anti orientation. The syn alignment of metal centers was accessible through the abstraction of halides ligands and incorporation of bridging groups as is the case for the pyrazine bridged bimetallic platinum complex [Pt2Me6(C4H4N2)(pmxda)][OSO2CF3]2

(OC-6-35)-(2,2′-Bipyridine-κ2 N,N′)dimeth­yl(3-sulfido­propionato-κ2 S,O)platinum(IV)

The title complex, [Pt(CH3)2(SCH2CH2CO2)(C10H8N2)], is formed by the unusual oxidative addition of the disulfide, R 2S2 (R = CH2CH2CO2H), to (2,2′-bipyridine)­dimethyl­platin­um(II) with elimination of RSH. The product contains an unusual six-membered thiol­ate–carboxyl­ate chelate ring. This slightly distorted octa­hedral complex exhibits cis angles ranging from 77.55 (11) to 97.30 (8)° due to the presence of the thiol­ate–carboxyl­ate chelate ring and the constrained bipyridine group. The crystal packing appears to be controlled by a combination of π-stacking [centroid–centroid distance = 3.611 (2) Å] and C—H⋯O inter­actions

Molecular Characterization of NRXN1 Deletions from 19,263 Clinical Microarray Cases Identifies Exons Important for Neurodevelopmental Disease Expression

PURPOSE: The purpose of the current study was to assess the penetrance of NRXN1 deletions. METHODS: We compared the prevalence and genomic extent of NRXN1 deletions identified among 19,263 clinically referred cases to that of 15,264 controls. The burden of additional clinically relevant copy-number variations (CNVs) was used as a proxy to estimate the relative penetrance of NRXN1 deletions. RESULTS: We identified 41 (0.21%) previously unreported exonic NRXN1 deletions ascertained for developmental delay/intellectual disability that were significantly greater than in controls (odds ratio (OR) = 8.14; 95% confidence interval (CI): 2.91-22.72; P \u3c 0.0001). Ten (22.7%) of these had a second clinically relevant CNV. Subjects with a deletion near the 3\u27 end of NRXN1 were significantly more likely to have a second rare CNV than subjects with a 5\u27 NRXN1 deletion (OR = 7.47; 95% CI: 2.36-23.61; P = 0.0006). The prevalence of intronic NRXN1 deletions was not statistically different between cases and controls (P = 0.618). The majority (63.2%) of intronic NRXN1 deletion cases had a second rare CNV at a prevalence twice as high as that for exonic NRXN1 deletion cases (P = 0.0035). CONCLUSIONS: The results support the importance of exons near the 5\u27 end of NRXN1 in the expression of neurodevelopmental disorders. Intronic NRXN1 deletions do not appear to substantially increase the risk for clinical phenotypes.Genet Med 19 1, 53-61

Plasma lipid profiles discriminate bacterial from viral infection in febrile children

Fever is the most common reason that children present to Emergency Departments. Clinical signs and symptoms suggestive of bacterial infection are often non-specific, and there is no definitive test for the accurate diagnosis of infection. The 'omics' approaches to identifying biomarkers from the host-response to bacterial infection are promising. In this study, lipidomic analysis was carried out with plasma samples obtained from febrile children with confirmed bacterial infection (n = 20) and confirmed viral infection (n = 20). We show for the first time that bacterial and viral infection produces distinct profile in the host lipidome. Some species of glycerophosphoinositol, sphingomyelin, lysophosphatidylcholine and cholesterol sulfate were higher in the confirmed virus infected group, while some species of fatty acids, glycerophosphocholine, glycerophosphoserine, lactosylceramide and bilirubin were lower in the confirmed virus infected group when compared with confirmed bacterial infected group. A combination of three lipids achieved an area under the receiver operating characteristic (ROC) curve of 0.911 (95% CI 0.81 to 0.98). This pilot study demonstrates the potential of metabolic biomarkers to assist clinicians in distinguishing bacterial from viral infection in febrile children, to facilitate effective clinical management and to the limit inappropriate use of antibiotics

Finishing the euchromatic sequence of the human genome

The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead

withdrawn 2017 hrs ehra ecas aphrs solaece expert consensus statement on catheter and surgical ablation of atrial fibrillation

n/

Plasma lipid profiles discriminate bacterial from viral infection in febrile children

Fever is the most common reason that children present to Emergency Departments. Clinical signs and symptoms suggestive of bacterial infection ar

Plasma lipid profiles discriminate bacterial from viral infection in febrile children

Fever is the most common reason that children present to Emergency Departments. Clinical signs and symptoms suggestive of bacterial infection are often non-specific, and there is no definitive test for the accurate diagnosis of infection. The 'omics' approaches to identifying biomarkers from the host-response to bacterial infection are promising. In this study, lipidomic analysis was carried out with plasma samples obtained from febrile children with confirmed bacterial infection (n = 20) and confirmed viral infection (n = 20). We show for the first time that bacterial and viral infection produces distinct profile in the host lipidome. Some species of glycerophosphoinositol, sphingomyelin, lysophosphatidylcholine and cholesterol sulfate were higher in the confirmed virus infected group, while some species of fatty acids, glycerophosphocholine, glycerophosphoserine, lactosylceramide and bilirubin were lower in the confirmed virus infected group when compared with confirmed bacterial infected group. A combination of three lipids achieved an area under the receiver operating characteristic (ROC) curve of 0.911 (95% CI 0.81 to 0.98). This pilot study demonstrates the potential of metabolic biomarkers to assist clinicians in distinguishing bacterial from viral infection in febrile children, to facilitate effective clinical management and to the limit inappropriate use of antibiotics

Increasing frailty is associated with higher prevalence and reduced recognition of delirium in older hospitalised inpatients: results of a multi-centre study

Purpose: Delirium is a neuropsychiatric disorder delineated by an acute change in cognition, attention, and consciousness. It is common, particularly in older adults, but poorly recognised. Frailty is the accumulation of deficits conferring an increased risk of adverse outcomes. We set out to determine how severity of frailty, as measured using the CFS, affected delirium rates, and recognition in hospitalised older people in the United Kingdom. Methods: Adults over 65 years were included in an observational multi-centre audit across UK hospitals, two prospective rounds, and one retrospective note review. Clinical Frailty Scale (CFS), delirium status, and 30-day outcomes were recorded. Results: The overall prevalence of delirium was 16.3% (483). Patients with delirium were more frail than patients without delirium (median CFS 6 vs 4). The risk of delirium was greater with increasing frailty [OR 2.9 (1.8–4.6) in CFS 4 vs 1–3; OR 12.4 (6.2–24.5) in CFS 8 vs 1–3]. Higher CFS was associated with reduced recognition of delirium (OR of 0.7 (0.3–1.9) in CFS 4 compared to 0.2 (0.1–0.7) in CFS 8). These risks were both independent of age and dementia. Conclusion: We have demonstrated an incremental increase in risk of delirium with increasing frailty. This has important clinical implications, suggesting that frailty may provide a more nuanced measure of vulnerability to delirium and poor outcomes. However, the most frail patients are least likely to have their delirium diagnosed and there is a significant lack of research into the underlying pathophysiology of both of these common geriatric syndromes